# Jardiance

NDC: 0597-0153
Generic name: Empagliflozin
Labeler / Manufacturer: Boehringer Ingelheim Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20140801

FDA application: NDA204629

## Active ingredients

- EMPAGLIFLOZIN: 25 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0597-0153"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0597-0153
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=faf3dd6a-9cd0-39c2-0d2e-232cb3f67565